China in Africa
China könnte bald Treibstoff-Ethanol nicht nur aus Biomasse herstellen, sondern auch aus Kohle
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Window-to-China
Guangzhou OED Technologies announces graphene electronic paper
The 0.225 nm thick material can be used to create hard or flexible graphene displays, used in electronic products such as e-readers and wearable smart devices.
Compared with traditional e-papers, graphene e-paper is more pliable and leads to optical displays of enhanced brightness.
China Bio news release, April 28, 2016
China will boost robot output in new 135″-plan”
According to the International Federation of Robotics, China is already the largest market for robots since 2013. According to the Ministry of Industry and Information Technology, the government will support Chinese robot producers such as Siasun Robot & Automation Co and Hubei Huachangda Intelligent Equipment Co. to boost international competitiveness through R&D and acquisitions and triple annual production to 100.000 robots in 2020.
CAS news release, April 27, 2016
China aims to become global aerospace power by 2030
According to XU Dazhe, Director of the China National Space Administration, China will complete its civilian space infrastructure system including satellite remote sensing, satellite communication and broadcasting, satellite navigation and positioning by about 2030.
CAS news release, April 25, 2016
CAS QIBEBT produces mussel adhesive analogues with underwater bonding strength up to 17.3 MPa
Based on the structural elements of mussel adhesive protein, the group of WAN Xiaobo at CAS Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) produced analogues based on PVP and catechol groups which, after underwater curing, reached a bonding strength of 1.6 MPa. After substituting PVP by PVA and heating at 140 ℃ for 20 min, a bonding strength of up to 17.3 MPa was achieved.
CAS news release, April 21, 2016
China’s WuXi Pharma Tech acquires Munich-based Crelux, a protein company
Crelux has developed a bi-turbo vector system which allows to express target proteins in parallel in E.coli and insect cells from the same plasmid construct. This procedure helps to produce pure proteins for x-ray structure analysis and for drug discovery purposes. The acquisition is in line with the rapid development of WuXi European operations.
China Bio news release, April 20, 2016
CAS Institute of Green and Intelligent Technology develops micro-g 3D printer for space applications
The Chongqing-based institute’s 3D printing research center has finished 93 zero gravity flying tests in France. The printer can produce bigger space parts than the one sent to the International Space Station by NASA late last month and could help China build a space station in 2020 and facilitate its operation and maintenance thereafter.
CAS news release, April 19, 2016
Wuxi Hospital pioneers genetic testing of pre-implanted human embryos
In this non-invasive embryo chromosome screening (NICS), DNA released from cultured embryos is sequenced prior to implantation. In China, more than 70 million women per year have tests on chromosomal abnormalities („assisted reproduction cycle“).
China Bio news release, April 18, 2016
Researchers at Central South University successfully transplant pig pancreas on 3 type-1 diabetes patients
The 3 patients have already survived for up to 3 years and all show reduced need of insulin injections.
CAS news release, April 18, 2016
Development and Reform Commission approves construction of 27 demonstration centers for genetic testing
The centers are planned to serve as a genetic test base for a personalized medicine („precision medicine“). Centers will be in Ningbo, Chengdu, Jining, Ningxia, Hunan and other locations.
China Bio, April 15, 2016
Ministry of Agriculture cracked down on illicit transgenic crop cultivation
According to a statement on April 13, the ministry has established a routine monitoring system aimed at the discovery of illicit cultivation of transgenic vegetables. Three cases concerning transgenic corn seed were discovered in Xinjiang, Gansu and Hainan, the plants grown on 1.000 and 100 acres, respectively, were destroyed and the field owners were punished.
China Bio news release, April 14, 2016
Guangzhou human embryo CRISPR study sparks controversy
A study at Guangzhou Medical University which used human embryos to make them resistant to HIV infection using CRISPR/CAS genome editing tools has led to discussions in China about strengthened legal supervision of such expeeriments. While the Guangzhou work was in line with China’s current regulations, some researchers saw a need for more precise regulations concerning the targets of such research and the ethics surrounding early human embryos.
China Bio news release, April 14, 2016
WuXi Pharma will join Huawei in developing a cloud platform for personalized medicine
The objective of this cooperation is to build a cloud-based platform for the development of a nation-wide genome-based personalized medicine („precision medicine“).
China Bio news release, April 14, 2016
Zhejiang Medical University, Harvard Medical School and United Biotechnology Co. build joint „Molecular Biotherapy Research Center“ inside Zhejiang University of Traditional Chinese Medicine
The 400 m2 laboratory will be led by Professor Guoping SHI of Harvard Medical School and focus on applications of regulatory T cell technology, e. g., for the treatment of lupus, organ transplantation and cancer.
China Bio news release, April 14, 2016
Chinese Space Center carries out micro-g 3D printing tests in Europe
A team of China’s Technology and Engineering Center for Space Utilization has completed 93 parabolic test flights in France leading to at least 22 seconds of microgravity. These flights were facilitated by the German DLR. During the flights, various 3D printing experiments with fiber-reinforced polymers were done using Chinese equipment and processes.
CAS news release, April 14, 2016
CAS Tianjin Institute of Industrial Biotechnology (TIB) signs erythromycin project with industrial consortium
The consortium comprises leading antibiotic produceers such as the Tonglian Group and Shenyang’s Chinese Academy of Technology. TIB’s HTS screening platform will be used to arrive at higher yields of the antibiotic of which China is already a major producer
CAS news release, April 12, 2016